Literature DB >> 27520088

An ex vivo lung model to study bronchioles infected with Pseudomonas aeruginosa biofilms.

Freya Harrison1,2, Stephen P Diggle2.   

Abstract

A key aim in microbiology is to determine the genetic and phenotypic bases of bacterial virulence, persistence and antimicrobial resistance in chronic biofilm infections. This requires tractable, high-throughput models that reflect the physical and chemical environment encountered in specific infection contexts. Such models will increase the predictive power of microbiological experiments and provide platforms for enhanced testing of novel antibacterial or antivirulence therapies. We present an optimized ex vivo model of cystic fibrosis lung infection: ex vivo culture of pig bronchiolar tissue in artificial cystic fibrosis mucus. We focus on the formation of biofilms by Pseudomonas aeruginosa. We show highly repeatable and specific formation of biofilms that resemble clinical biofilms by a commonly studied laboratory strain and ten cystic fibrosis isolates of this key opportunistic pathogen.

Entities:  

Mesh:

Year:  2016        PMID: 27520088     DOI: 10.1099/mic.0.000352

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  12 in total

Review 1.  Options and Limitations in Clinical Investigation of Bacterial Biofilms.

Authors:  Maria Magana; Christina Sereti; Anastasios Ioannidis; Courtney A Mitchell; Anthony R Ball; Emmanouil Magiorkinis; Stylianos Chatzipanagiotou; Michael R Hamblin; Maria Hadjifrangiskou; George P Tegos
Journal:  Clin Microbiol Rev       Date:  2018-04-04       Impact factor: 26.132

Review 2.  Biofilms: Formation, Research Models, Potential Targets, and Methods for Prevention and Treatment.

Authors:  Yajuan Su; Jaime T Yrastorza; Mitchell Matis; Jenna Cusick; Siwei Zhao; Guangshun Wang; Jingwei Xie
Journal:  Adv Sci (Weinh)       Date:  2022-08-28       Impact factor: 17.521

Review 3.  The biogeography of infection revisited.

Authors:  Sheyda Azimi; Gina R Lewin; Marvin Whiteley
Journal:  Nat Rev Microbiol       Date:  2022-02-08       Impact factor: 78.297

4.  An in vitro model for the cultivation of polymicrobial biofilms under continuous-flow conditions.

Authors:  Thomas James O'Brien; Marwa Mohsen Hassan; Freya Harrison; Martin Welch
Journal:  F1000Res       Date:  2021-08-13

5.  Microbial Musings - January 2021.

Authors:  Gavin H Thomas
Journal:  Microbiology (Reading)       Date:  2021-01       Impact factor: 2.777

6.  Visualizing Antimicrobials in Bacterial Biofilms: Three-Dimensional Biochemical Imaging Using TOF-SIMS.

Authors:  Sarah K Davies; Sarah Fearn; Luke P Allsopp; Freya Harrison; Ecaterina Ware; Stephen P Diggle; Alain Filloux; David S McPhail; Jacob G Bundy
Journal:  mSphere       Date:  2017-07-19       Impact factor: 4.389

7.  Optimised chronic infection models demonstrate that siderophore 'cheating' in Pseudomonas aeruginosa is context specific.

Authors:  Freya Harrison; Alan McNally; Ana C da Silva; Stephan Heeb; Stephen P Diggle
Journal:  ISME J       Date:  2017-07-11       Impact factor: 10.302

8.  Effect of host-mimicking medium and biofilm growth on the ability of colistin to kill Pseudomonas aeruginosa.

Authors:  Esther Sweeney; Akshay Sabnis; Andrew M Edwards; Freya Harrison
Journal:  Microbiology (Reading)       Date:  2020-12       Impact factor: 2.777

9.  The Antimicrobial Activity of a Carbon Monoxide Releasing Molecule (EBOR-CORM-1) Is Shaped by Intraspecific Variation within Pseudomonas aeruginosa Populations.

Authors:  Lindsey Flanagan; Rachel R Steen; Karinna Saxby; Mirre Klatter; Benjamin J Aucott; Craig Winstanley; Ian J S Fairlamb; Jason M Lynam; Alison Parkin; Ville-Petri Friman
Journal:  Front Microbiol       Date:  2018-02-08       Impact factor: 5.640

10.  Predicting Antibiotic-Associated Virulence of Pseudomonas aeruginosa Using an ex vivo Lung Biofilm Model.

Authors:  Marwa M Hassan; Niamh E Harrington; Esther Sweeney; Freya Harrison
Journal:  Front Microbiol       Date:  2020-09-02       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.